ACS Medicinal Chemistry Letters
Page 6 of 7
1
2
resistant Candida infections. Diagn. Microbiol. Infect. Dis. 2003,
(29) Premachandra, I. D. U. A.; Scott, K. A.; Shen, C.; Wang, F.;
46, 227–31.
Lane, S.; Liu, H.; Van Vranken, D. L. Potent Synergy between
Spirocyclic Pyrrolidinoindolinones and Fluconazole against Canꢀ
dida albicans. ChemMedChem. 2015, 10, 1672–1686.
3
4
5
6
7
8
9
(15) Onyewu, C.; Blankenship, J.; Del Poeta, M.; Heitman, J. Erꢀ
gosterol biosynthesis inhibitors become fungicidal when combined
with calcineurin inhibitors against Candida albicans, Candida glaꢀ
brata, and Candida krusei. Antimicrob. Agents Chemother. 2003, 47,
956–964.
(16) Sun, S.; Li, Y.; Guo, Q.; Shi, C.; Yu, J.; Ma, L. In vitro inꢀ
terꢀ actions between tacrolimus and azoles against Candida albicans
determined by different methods. Antimicrob. Agents Chemother.
2008, 52, 409–417.
(17) Uppuluri, P.; Nett, J.; Heitman, J.; Andes, D. Synergistic efꢀ
fect of calcineurin inhibitors and fluconazole against Candida albi-
cans biofilms. Antimicrob. Agents Chemother. 2008, 52, 1127–
1132.
(18) Denardi, L.; Mario, D.; Loreto, É.; Santurio, J.; Alves, S.
Synergistic effects of tacrolimus and azole antifungal compounds in
fluconazoleꢀsusceptible and fluconazoleꢀresistant Candida glabrata
isolates Braz. J. Microbiol. 2015, 46, 125–129.
(19) Steinbach, W.; Schell, W.; Blankenship, J.; Onyewu, C.;
Heitman, J.; Perfect, J.; In vitro interactions between antifungals
and immunosuppressants against Aspergillus fumigatus. Antimicrob.
Agents Chemother. 2004, 48, 1664–1669.
(20) Te Dorsthorst, D.; Verweij, P.; Meletiadis, J.; Bergervoet,
M.; Punt, N; Meis, J.; Mouton, J. In vitro interaction of flucytosine
combined with amphotericin B or fluconazole against thirtyꢀfive
yeast isolates determined by both the fractional inhibitory concenꢀ
tration index and the response surface approach. Antimicrob. Agents
Chemother. 2002, 46, 2982–2989.
(21) Johnson, M.; MacDougall, C.; OstroskyꢀZeichner, L.; Perꢀ
fect, J.; Rex, J. Combination Antifungal Therapy Antimicrob.
Agents Chemother. 2004, 48, 693–715.
(22) Kuypers, D.; Claes, K.; Evenepoel, P.; Vanrenterghem, Y.
Clinically Relevant Drug Interaction Between Voriconazole and
Tacrolimus in a Primary Renal Allograft Recipient. Transplanta-
tion. 2006, 81, 1750–1752.
(23) Imbert, S.; Bresler, P.; Boissonnas, A.; Gauthier, L.; Souꢀ
chet, L.; Uzunov, M.; Leblond, V.; Mazier, D.; Nguyen, S.; Fekkar,
A. Calcineurin inhibitors impair neutrophil activity against Asper-
gillus fumigatus in allogenic hematopoietic stem cell transplant
recipients. J. Allergy Clin. Immunol. published online April 7, 2016;
DOI: 10.1016/j.jaci.2016.02.026.
(24) DoddsꢀAshley, E. Management of drug and food interacꢀ
tions with azole antifungal agents in transplant recipients. Pharma-
cotherapy 2010, 30, 842–854.
(25) National Center for Biotechnology Information. PubChem
BioAssay Database; AID=2007, Source=Broad Institute.
cessed Mar. 11, 2015).
(26) Youngsaye, W.; Hartland, C.; Morgan, B.; Ting, A.; Nag, P.;
Vincent, B.; Mosher, C.; Bittker, J.; Dandapani, S.; Palmer, M.;
Whitesell, L.; Lindquist, S.; Schreiber, S.; Munoz, B. ML212: A
smallꢀmolecule probe for investigating fluconazole resistance
mechanisms in Candida albicans. Beilstein J. Org. Chem. 2013, 9,
1501–1507.
(27) Youngsaye, W.; Vincent, B.; Hartland, C.; Morgan, B.;
Buhrlage, S.; Johnston, S.; Bittker, J.; MacPherson, L.; Dandapani,
S.; Palmer, M.; Whitesell, L.; Lindquist, S.; Schreiber, S.; Munoz,
B. Piperazinyl quinolines as chemosensitizers to increase fluconaꢀ
zole susceptibility of Candida albicans clinical isolates. Bioorg.
Med. Chem. Lett. 2011, 21, 5502–5505.
(28) Youngsaye, W.; Dockendorff, C.; Vincent, B.; Hartland, C.;
Bittker, J.; Dandapani, S.; Palmer, M.; Whitesell, L.; Lindquist, S.;
Schreiber, S. L.; Munoz, B. Overcoming fluconazole resistance in
Candida albicans clinical isolates with tetracyclic indoles. Bioorg.
Med. Chem. Lett. 2012, 22, 3362–3365.
(
30) Wolfbeis, O. Liebigs Ann. Chem. Synthesen von Fluoꢀ
reszenzfarbstoffen, 11 über die Umlagerung von Alkoxymethylenꢀ
und Aminomethylenhomophthalsäureanhydriden zu Isocumarinen
bzw. Isochinolinonen 1981, 5, 819–827.
(
31) Patil, C. D.; Sadana, A.; Deodhar, S. Syntheses of 2ꢀ
substitutedꢀ1,2ꢀdihydroꢀ1ꢀoxoꢀ4ꢀisoquinolineꢀcarboxamides and 4ꢀ
amidoximinoꢀ2ꢀsubstitutedꢀ1,2ꢀdihydroꢀ1ꢀoxoisoquinolines as anꢀ
timicrobial agents. J. Indian Chem. Soc. 1990, 67, 654–656.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(
32) Dieckmann, W.; Meiser, W. Über Homophthalsäureester,
Oxymethylenꢀhomophthalsäureester und die aus ihm entstehenden
Isocumarinꢀund IsocarbostyrilꢀDerivate Chem. Ber. 1908, 41, 3253–
3269.
(
33) Liu, B.; Yi, W.; Zhang, J.; Liu, Q.; Liu, Y.; Fan, S.; Yu, X.
Synthesis and gene transfection of cyclenꢀbased cationic lipids with
asymmetric acylꢀcholesteryl hydrophobic tails. Org. Biomol. Chem.
2014, 12, 3484–3492.
(
34) Zinelaabidine, C.; Souad, O.; Zoubir, J,; Malika, B.; Nourꢀ
Eddine, A. A Simple and Efficient Green Method for the Deprotecꢀ
tion of NꢀBoc in Various Structurally Diverse Amines under Waterꢀ
mediated Catalystꢀfree Conditions Int. J. Chem. 2012, 4, 73–79.
(
35) Martin, L.; Coello, M.; Reyes, B.; Rodriguez, V.; Garranzo,
G.; Murcia, P.; Francesch, S.; Sanchez, S.; Fernandez, R. Antiꢀ
tumoral dihydropyranꢀ2ꢀone compounds. WO Patent 2007 144 423,
2007.
(
36) Liu, Z., Wang, R.; Guo, R.; Hu, J.; Li, R.; Zhao, Y.; Gong,
P. Design, synthesis and biological evaluation of novel 6,7ꢀ
disubstitutedꢀ4ꢀphenoxyquinoline derivatives bearing 4ꢀoxoꢀ3,4ꢀ
dihydrophthalazineꢀ1ꢀcarboxamide moieties as cꢀMet kinase inhibiꢀ
tors. Bioorg. Med. Chem. 2014, 22, 3642–3653.
(
37) Flowers, S.; Barker, K.; Berkow, E.; Toner, G.; Chadwick,
S.; Gygax, S.; Morschhauser, J.; Rogers, D. GainꢀofꢀFunction Mutaꢀ
tions in UPC2 Are a Frequent Cause of ERG11 Upregulation in
AzoleꢀResistant Clinical Isolates of Candida albicans. Eukaryotic
Cell 2012, 11, 1289–1299.
(38) Warrilow A.G.; Martel, C.M.; Parker, J.E.; Melo, N.; Lamb,
D.C.; Nes, W.D.; Kelly, D.E.; Kelly, S.L. Azole Binding Properties
of Candida albicans Sterol 14ꢀα Demethylase (CaCYP51). Antimi-
crob. Agents Chemotherm. 2010, 54, 4235ꢀ4245.
(
39) Cormack, B. P.; Falkow, S. Efficient homologous and
illegitimate recombination in the opportunistic yeast pathogen
Candida glabrata. Genetics. 1999, 151, 979–87.
(40) Fidel, P.L.;Cutright, J.L.; Tait, L.; Sobel, J.D.; A Murine
Model of Candida glabrata Vaginitis. 1996, 173, 425ꢀ431.
(acꢀ
(
41) Janbon, G. et. al. Analysis of the Genome and Transcripꢀ
tome of Cryptococcus neoformans var. grubii Reveals Complex
RNA Expression and Microevolution Leading to Virulence Attenꢀ
uation. PLoS Genet. 2014, 10, 1ꢀ26.
ACS Paragon Plus Environment